Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Future Oncology (London, England)
|
September 21, 2019
The role of obinutuzumab in the management of follicular lymphoma
Jenny O'Nions, William Townsend
Oncogene
|
October 17, 2003
Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2
Jenny O'Nions, Martin J Allday
The Journal of General Virology
|
March 25, 2004
Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens
Jenny O'Nions, Martin J Allday
BMJ Case Reports
|
August 6, 2013
A complex neurological presentation of syphilis
Max Kamath, Maleeha Rizvi, Jenny O'Nions, et al.
The Journal of General Virology
|
April 16, 2005
Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells
Robert Touitou, Jenny O'Nions, Judith Heaney, et al.
Journal of Virology
|
September 22, 2006
Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53
Jenny O'Nions, Abigail Turner, Richard Craig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2014
Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause
Philip Savage, Rosie Cooke, Jenny O'Nions, et al.
Blood
|
September 15, 2005
Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies
Nelofer Syed, Paul Smith, Alexandra Sullivan, et al.
Blood
|
November 1, 2024
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
Curtis A Lachowiez, Vishvaas I Ravikumar, Jad Othman, et al.
Current Research in Translational Medicine
|
January 23, 2024
Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms'
Dipal Mehta, Samah Alimam, Donal P McLornan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Future Oncology (London, England)
|
September 21, 2019
The role of obinutuzumab in the management of follicular lymphoma
Jenny O'Nions, William Townsend
Oncogene
|
October 17, 2003
Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2
Jenny O'Nions, Martin J Allday
The Journal of General Virology
|
March 25, 2004
Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens
Jenny O'Nions, Martin J Allday
BMJ Case Reports
|
August 6, 2013
A complex neurological presentation of syphilis
Max Kamath, Maleeha Rizvi, Jenny O'Nions, et al.
The Journal of General Virology
|
April 16, 2005
Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells
Robert Touitou, Jenny O'Nions, Judith Heaney, et al.
Journal of Virology
|
September 22, 2006
Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53
Jenny O'Nions, Abigail Turner, Richard Craig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2014
Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause
Philip Savage, Rosie Cooke, Jenny O'Nions, et al.
Blood
|
September 15, 2005
Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies
Nelofer Syed, Paul Smith, Alexandra Sullivan, et al.
Blood
|
November 1, 2024
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
Curtis A Lachowiez, Vishvaas I Ravikumar, Jad Othman, et al.
Current Research in Translational Medicine
|
January 23, 2024
Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms'
Dipal Mehta, Samah Alimam, Donal P McLornan, et al.
Page
of 3